Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld MedTech
BioWorld MedTech
Oct. 25, 2010
View Archived Issues
Experimental device could lead to safer chemo treatments
Read More
Court Report: Sorin completes $10 million settlement on Ela subsidiary
Read More
Med-Tech Notes
Read More
Grants roundup: USDA to give Unilife $10M for new HQ construction
Read More
Medical Device Daily Fun Facts
Read More
Agreements/contracts: Premier, SRI Surgical in multiple agreements
Read More
People in the News
Read More
HIT roundup: Recondo launches financial assistance software service
Read More
Product Briefs
Read More
MDD's Neurology Extra
Read More
Deals roundup: GE Healthcare to acquire Clarient for $580M in cash
GE Healthcare (Chalfont St Giles, UK) said it has agreed to acquire Clarient (Aliso Viejo, California), a molecular diagnostics company, in a deal valued at $580 million. (Medical Device Daily)
Read More
Report from Europe: Boston Sci gets CE mark for WallFlex Biliary RX stent
Read More
Washington roundup: Health Canada drafts guidance for class III and IV applications
Read More
Financings roundup: St. Jude authorizes $300M share repurchase program
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe